{"transactions":[{"id":2411241,"issuer":{"id":7139,"kind":"organization","name":"ImageneBio, Inc."},"owners":[{"id":130769,"kind":"person","name":"Tessier Maude","position":1,"cik":"0001848534","reported_name":"Tessier Maude","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-04T23:09:32.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest and become exercisable on January 1, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":40000,"derivative":{"exercise_price":11.45,"expiration_date":"2032-02-02","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-22-004878","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835579/000089924322004878/doc4.xml","form_type":"4"}},{"id":2429566,"issuer":{"id":7139,"kind":"organization","name":"ImageneBio, Inc."},"owners":[{"id":130769,"kind":"person","name":"Tessier Maude","position":1,"cik":"0001848534","reported_name":"Tessier Maude","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T21:30:43.000Z","date":"2022-01-18","kind":"exercise","acquired":false,"shares":8265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of this option vested and became exercisable on December 6, 2020, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":28963,"derivative":{"exercise_price":4.51,"expiration_date":"2029-12-05","underlying":"Common Stock","underlying_shares":8265},"source":{"system":"sec-edgar","filing":"0000899243-22-002657","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1835579/000089924322002657/doc4.xml","form_type":"4"}},{"id":2429565,"issuer":{"id":7139,"kind":"organization","name":"ImageneBio, Inc."},"owners":[{"id":130769,"kind":"person","name":"Tessier Maude","position":1,"cik":"0001848534","reported_name":"Tessier Maude","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T21:30:43.000Z","date":"2022-01-18","kind":"exercise","acquired":false,"shares":24606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of this option vested and became exercisable on March 20, 2020, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":11186,"derivative":{"exercise_price":4.15,"expiration_date":"2029-03-19","underlying":"Common Stock","underlying_shares":24606},"source":{"system":"sec-edgar","filing":"0000899243-22-002657","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1835579/000089924322002657/doc4.xml","form_type":"4"}},{"id":2429564,"issuer":{"id":7139,"kind":"organization","name":"ImageneBio, Inc."},"owners":[{"id":130769,"kind":"person","name":"Tessier Maude","position":1,"cik":"0001848534","reported_name":"Tessier Maude","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T21:30:43.000Z","date":"2022-01-18","kind":"exercise","acquired":false,"shares":38915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option vested and became exercisable on July 16, 2019, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":5560,"derivative":{"exercise_price":2.94,"expiration_date":"2028-08-08","underlying":"Common Stock","underlying_shares":38915},"source":{"system":"sec-edgar","filing":"0000899243-22-002657","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1835579/000089924322002657/doc4.xml","form_type":"4"}},{"id":2429563,"issuer":{"id":7139,"kind":"organization","name":"ImageneBio, Inc."},"owners":[{"id":130769,"kind":"person","name":"Tessier Maude","position":1,"cik":"0001848534","reported_name":"Tessier Maude","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2022-01-20T21:30:43.000Z","date":"2022-01-18","kind":"exercise","acquired":true,"shares":8265,"price":4.51,"value":37275.15,"ownership":{"direct":true},"balance_after":100578,"source":{"system":"sec-edgar","filing":"0000899243-22-002657","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1835579/000089924322002657/doc4.xml","form_type":"4"}},{"id":2429562,"issuer":{"id":7139,"kind":"organization","name":"ImageneBio, Inc."},"owners":[{"id":130769,"kind":"person","name":"Tessier Maude","position":1,"cik":"0001848534","reported_name":"Tessier Maude","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2022-01-20T21:30:43.000Z","date":"2022-01-18","kind":"exercise","acquired":true,"shares":24606,"price":4.15,"value":102114.9,"ownership":{"direct":true},"balance_after":92313,"source":{"system":"sec-edgar","filing":"0000899243-22-002657","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1835579/000089924322002657/doc4.xml","form_type":"4"}},{"id":2429561,"issuer":{"id":7139,"kind":"organization","name":"ImageneBio, Inc."},"owners":[{"id":130769,"kind":"person","name":"Tessier Maude","position":1,"cik":"0001848534","reported_name":"Tessier Maude","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2022-01-20T21:30:43.000Z","date":"2022-01-18","kind":"exercise","acquired":true,"shares":38915,"price":2.94,"value":114410.1,"ownership":{"direct":true},"balance_after":67707,"source":{"system":"sec-edgar","filing":"0000899243-22-002657","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835579/000089924322002657/doc4.xml","form_type":"4"}}]}